TrialDiabetologia2021

Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers.

Frank Pistrosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.